Moreover, the presented results did not ultimately show that lycopene has no role in cancer treatment, as one subgroup of patients had stable prostate-specific antigen (PSA), which was interpreted as a negative result consistent with the primary endpoint of PSA reduction, but stabilisation might have been the benefit brought by lycopene [48]. This evidence concerns the gene KLK3 and cancer.